These diabetes and weight-loss drugs might help prevent or lessen health problems caused by obesity, like heart disease or diabetes.
Evidence from Studies
Supporting (2)
Community contributions welcome
The study shows that a diabetes drug called semaglutide helps reduce inflammation and improve heart-related symptoms in people with obesity, which supports the idea that it can help with health problems linked to obesity.
GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease.
The study shows that drugs like semaglutide and tirzepatide help people with obesity by improving heart health, blood sugar, and liver and cholesterol levels, which means they reduce serious health problems linked to obesity.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.